Literature DB >> 22284352

Established and emerging trends in computational drug discovery in the structural genomics era.

Olivier Taboureau1, Jonathan B Baell, Juan Fernández-Recio, Bruno O Villoutreix.   

Abstract

Bioinformatics and chemoinformatics approaches contribute to hit discovery, hit-to-lead optimization, safety profiling, and target identification and enhance our overall understanding of the health and disease states. A vast repertoire of computational methods has been reported and increasingly combined in order to address more and more challenging targets or complex molecular mechanisms in the context of large-scale integration of structure and bioactivity data produced by private and public drug research. This review explores some key computational methods directly linked to drug discovery and chemical biology with a special emphasis on compound collection preparation, virtual screening, protein docking, and systems pharmacology. A list of generally freely available software packages and online resources is provided, and examples of successful applications are briefly commented upon.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22284352     DOI: 10.1016/j.chembiol.2011.12.007

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  13 in total

1.  Emerging topics in structure-based virtual screening.

Authors:  Giulio Rastelli
Journal:  Pharm Res       Date:  2013-03-07       Impact factor: 4.200

2.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.

Authors:  Daniel Reker; Tiago Rodrigues; Petra Schneider; Gisbert Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

3.  Solution structure of the sortase required for efficient production of infectious Bacillus anthracis spores.

Authors:  Scott A Robson; Alex W Jacobitz; Martin L Phillips; Robert T Clubb
Journal:  Biochemistry       Date:  2012-09-27       Impact factor: 3.162

4.  Quantum Mechanics Approaches to Drug Research in the Era of Structural Chemogenomics.

Authors:  Andrey V Ilatovskiy; Ruben Abagyan; Irina Kufareva
Journal:  Int J Quantum Chem       Date:  2013-06-15       Impact factor: 2.444

Review 5.  Role of Structural Bioinformatics in Drug Discovery by Computational SNP Analysis: Analyzing Variation at the Protein Level.

Authors:  David K Brown; Özlem Tastan Bishop
Journal:  Glob Heart       Date:  2017-03-13

6.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.

Authors:  Cheryl Carson; Pichai Raman; Jennifer Tullai; Lei Xu; Martin Henault; Emily Thomas; Sarita Yeola; Jianmin Lao; Mark McPate; J Martin Verkuyl; George Marsh; Jason Sarber; Adam Amaral; Scott Bailey; Danuta Lubicka; Helen Pham; Nicolette Miranda; Jian Ding; Hai-Ming Tang; Haisong Ju; Pamela Tranter; Nan Ji; Philipp Krastel; Rishi K Jain; Andrew M Schumacher; Joseph J Loureiro; Elizabeth George; Giuliano Berellini; Nathan T Ross; Simon M Bushell; Gül Erdemli; Jonathan M Solomon
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 7.  Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.

Authors:  Bruno O Villoutreix; Melaine A Kuenemann; Jean-Luc Poyet; Heriberto Bruzzoni-Giovanelli; Céline Labbé; David Lagorce; Olivier Sperandio; Maria A Miteva
Journal:  Mol Inform       Date:  2014-06-02       Impact factor: 3.353

8.  StreptomeDB: a resource for natural compounds isolated from Streptomyces species.

Authors:  Xavier Lucas; Christian Senger; Anika Erxleben; Björn A Grüning; Kersten Döring; Johannes Mosch; Stephan Flemming; Stefan Günther
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

9.  In silico mechanistic profiling to probe small molecule binding to sulfotransferases.

Authors:  Virginie Y Martiny; Pablo Carbonell; David Lagorce; Bruno O Villoutreix; Gautier Moroy; Maria A Miteva
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

10.  Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation.

Authors:  Yu Cao; Cheng Wang; Xueli Zhang; Guichun Xing; Kefeng Lu; Yongqing Gu; Fuchu He; Lingqiang Zhang
Journal:  Sci Rep       Date:  2014-05-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.